News & AnalysisVisus Therapeutics rakes in $36mVisus Therapeutics Inc, a developer of eye drops, has raised $36 million in funding.ByIris Dorbian9 March 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs